StockMarketWire.com - Jefferies International today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 5950p (from 5600p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk